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ABSTRACT 
Objective: The aim of this study was to compare the preservative efficacy of benzalkonium chloride, thimerosal and benzyl alcohol in eye drops 
formulation containing chloramphenicol as the active agents for producing the sterile and effective eye drops. 
Methods: The efficacy of preservatives was assayed by evaluating the physical appearance, pH stability, sterility and the antibacterial effectivity of 
the formulated eye drops. Each of 0.5% chloramphenicol was formulated with different preservatives of benzalkonium chloride, thimerosal and 
benzyl alcohol at its recommended concentration, 0.01%; 0.01% and 1%, respectively. The in vitro stability was examined periodically for the eye 
drops formulation stored at room temperature during the 28-day period. The effectiveness of the antibacterial effect of chloramphenicol in eye 
drops was assayed by using the agar diffusion method against Escherichia coli and evaluated for the diameter of inhibition zones.  
Result: The clarity of the eye drops formula produced clear solutions. The eye drops formula exhibited relatively stabile on pH. All the formulated 
eye drops were sterile during the storage time. The appropriate of the sterilization method was thought to contribute to the sterility of eye drops 
which did not contain preservatives. In addition, it was assumed that the pre-reaction of chloramphenicol in inhibiting the contaminants in the eye 
drop may occur during the storage time. This hypothesis was confirmed by the inhibitory diameter stability produced by the eye drop formulas 
containing preservatives compared to that of not. The decrease in inhibition diameter occurred during the storage period (28 d) of each formula 
was as follows: F0 (51.58%), F1 (35.76%), F2 (31.86%), and F3 (35.35%). The best stability based on the antibacterial activity of the 
chloramphenicol eye drops was produced by F2 which used 0.01% thimerosal as its preservative. The differences in inhibition diameter were 
significantly influenced by the presence and the type of preservatives.  
Conclusion: 0.01% thimerosal indicated the best improvement on the efficacy of 0.5% chloramphenicol eye drop. 
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INTRODUCTION 
Bacterial conjunctivitis is a highly contagious eye infection signed 
with red eye, tearing, and discharge from one or both eyes that more 
common in infants and children than in adults [1]. The sources of 
eye contaminants can be originated from various sources of 
environmental contamination, both directly infect the eye through 
the wear of contact lens or from the contaminated eye drops in the 
multidose form [2, 3]. The main causative bacteria are Streptococcus 
pneumoniae, Haemophilus influenza, and Staphylococcus aureus [4, 
5]. Among those bacteria, S. aureus is commonly found in adults and 
the elderly than in children cases. These bacteria can spread through 
contact with patients, such as eye contact, hand, fomite, and 
respiratory droplets [6]. Direct exposure of bacteria onto the 
conjunctiva generates to infectious conjunctivitis [2]. Subsequent 
infections caused by the bacterial contamination can pose a serious 
threat to human health. Bacterial conjunctivitis in individuals which 
wear contact lens have a risk to be subsequent as bacterial keratitis, 
an infection which is more severe than conjunctivitis [4, 5]. In 
addition, the contamination can be sourced from the eye drop 
product, which reported mostly from the caps (45.9%), droppers 
(41.0%) and residual contents (13.1%) [7]. 
Studies have revealed that approximately 50 percent of infectious 
conjunctivitis in pediatric are related to bacteria, thus physicians 
administer antibiotics in the majority of these cases [  Actually, 
acute bacterial conjunctivitis is often a self-limiting disease, but the 
use of antibiotics can significantly increase the level of clinical and 
microbiological improvement [10]. The most frequently treatment 
to treat bacterial conjunctivitis is a topical application such as eye 
drops or eye ointment because it is easy to use, can provide high 
drug concentrations, and evade systemic absorption [11]. 
Chloramphenicol is the gold standard and the most common active 
drug prescribed in the topical application to treat bacterial 
conjunctivitis [12, 13]. Chloramphenicol significantly inhibited the 
growth of eye pathogens up to 94% and its efficacy in ocular 
infections was 91-93% [14, 15]. Meanwhile, traditional medicines 
are not recommended for eye treatment because they are reportedly 
involved as a major risk factor in the current corneal ulceration 
epidemic in developing countries [16]. But the use of antibiotics in 
eye drops is not always safe, especially in multidose eye drops. 
Unfortunately, ocular solutions used for therapeutic purposes were 
reported to be contaminated with pathogens and caused serious eye 
infections such as endophthalmitis and keratitis [17]. The 
contamination rate of multidose eye drops was reported to be 
higher in bottles that have been opened for two weeks than that of 
unopened. Most of the samples were contaminated by coagulase-
negative Staphylococci, while nine other samples were 
contaminated by different microorganisms. The role of 
benzalkonium chloride as the preservative in these eye drops 
preparations was reported to be ineffective, because it still yielded a 
fairly high level of contamination (34.4%) [18].  
8, 9]. 
The primary objective of preservatives addition into eye drops 
products is to inhibit the microbial growth, which can cause active 
drug degradation [19, 20]. Thus, the product sterility is maintained 
during use. In addition to its effectiveness, an important thing to be 
considered in the selection of preservatives is the cytotoxic effect 
that can occur in the long term-therapy, especially in eye drops 
using multiple preserved drugs. As reported in another study, the 
stabilized oxychloro complex can damage the rabbit corneal 
epithelial cells and benzalkonium chloride showed cytotoxic effects 
in cell culture, both in animal or human research [21]. Another 
preservative that has been reported to be most effective in killing 
99.6 % of the microorganism present was benzyl alcohol, but the 
toxicity of benzyl alcohol in human retinal pigment epithelial (RPE) 
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cells had been reported [22, 23]. The United States Centers for 
Disease Control and Prevention declares that thimerosal is a safe 
preservative and disclaimed the statement that thimerosal-
containing vaccine preservative was related to autism cases in 
children [19]. Therefore, it is important to determine the type of 
effective preservative in eye drops formulations containing 
chloramphenicol antibiotics to ensure the antimicrobial activity 
against the contaminants and to prevent the active drug from 
structure degradation.  
MATERIALS AND METHODS 
Materials 
Escherichia coli ATCC 25922, Bacillus subtillis ATCC 6633 and 
Candida albicans ATCC 10231 were used in this study and obtained 
from the Laboratory of Microbiology, Faculty of Pharmacy, 
Padjajaran University, Indonesia. The bacterial growth medium used 
were Mueller Hinton Broth/MHB (Oxoid), Mueller Hinton 
Agar/MHA (Oxoid), Soybean-Casein Digest Broth/SCDB (Pronadisa) 
and Fluid Thioglicolate Medium/FTM (Oxoid). The chemicals used 
include chloramphenicol (PT. Cendo), boric acid (Merck), sodium 
tetraborate (Merck), redistillata water (PT. Ikapharmindo 
Indonesia), and 70% alcohol (PT. Brataco Indonesia).  
Formulation of 0.5% chloramphenicol eye drops  
Eye drops consisted of four formulations with the addition of 
different preservatives, including benzalkonium chloride, 
thimerosal, and benzyl alcohol. The formulas were a negative 
control formula (without preservative), presented in table 1. The eye 
drop formulation consisted of a positive control formula (F1) with a 
0.01% preservative concentration and the remains formulas were 
tested formula which formulated with the addition of 0.01 % 
benzalkonium chloride (F1), 0.01% thimerosal (F2), and 1 % benzyl 
alcohol (F3). 
  
Table 1: 0.5% Chloramphenicol eye drop formula 
Composition F0 (%) F1 (%) F2 (%) F3 (%) 
Chloramphenicol 0.50 0.50 0.50 0.50 
Boric acid 1.50 1.50 1.50 1.50 
Sodium tetraborate 0.30 0.30 0.30 0.30 
Benzalkonium chloride 0.00 0.01 0.00 0.00 
Thimerosal 0.00 0.00 0.01 0.00 
Benzyl alcohol 0.00 0.00 0.00 1.00 
Sterile aqua pro injection (API) Ad 100 Ad 100 Ad 100 Ad 100 
 
The chloramphenicol, sodium tetraborate and boric acid were 
mixed, then dissolved in a part of the sterile aqua pro injection. After 
dissolving, the preservative solution was added and the remaining 
sterile API was mixed and homogenized. Then the pH of each eye 
drop solution was measured. The solution was then sterilized using 
bacterial filter. The sterilized preparations were stored at room 
temperature and protected from the sunlight. Observations were 
made on days of 1, 3, 7, 14, 21 and 28. 
Evaluation  
Clarity  
The clarity and color changes of the eye drops preparation were 
inspected visually based on the level of turbidity of the product or 
the presence of floating particles in the eye drops solution. 
pH 
pH of the eye drops solution was measured by a pH meter.  
Sterility test 
A loopful of B. subtilis colony was inoculated in FTM medium and 
incubated at 30-35 °C for 18 h. Meanwhile the C. albicans colony 
used SCDB medium as the growth medium and incubated at 20-25 
°C for 72 h. The resulted of microbial incubation was adjusted to the 
certain turbidity that equivalent to 0.5 Mc Farland (1.5x108cfu/ml). 
The microbial suspension, then diluted to 1 x 107cfu/ml [24]
The eye drops preparation was pipetted for 2 ml and each of 1 ml of 
it was homogenized in FTM and SCD medium, then incubated based 
on the intended microbial contamination target. To check the 
presence of bacterial contamination in the aye drop preparation, the 
tested FTM media were incubated at at 30-35 °C for no less than 14 
d. Meanwhile, the fungal contamination presence can be detected 
after the tested SCD medium was incubated at a temperature of 20-
25 °C for no less than 7 d. The presences of the contaminants were 
evaluated by observing the turbidity of the media everyday, 
compared to control tube containing the uninoculated FTM media or 
SCD media and positive control containing the inoculated media. 
FTM media were inoculated with B. subtilis, and the SCD media were 
inoculated with C. albicans, as the positive control [25]. 
. Before 
the media were used for the sterility test, the fertility test must be 
conducted to certify that the FTM and SCDB media were free from 
substances which may inhibit the microbial growth. The growth of B. 
subtilis indicated the fertility of the FTM medium and C. albicans 
growth in the SCDB media as fungal indicator. As the procedure of 
the fertility test, the inoculated FTM was incubated at 30-35 °C for 7 
d, whereas the SCDB inoculated medium was incubated at 20-25 °C 
for 3 d. The turbidity of the bacterial and fungal suspension 
indicated the bacterial or fungal growth. The sterility of the 
uninoculated media was evaluated by incubating the media at the 
same condition as the fertility test [25].  
Efficacy test 
A standardized of E. coli (0.5 Mac Farland turbidity standard) in a 
volume of 20 µl was inoculated into 20 ml sterile MHA. The media 
was allowed to solidify, then perforated and filled with a 50 µl of 
each eye drops preparation formulas. The tested media were 
incubated for 18-24 h at 37 °C. The presence of inhibition zones was 
documented and the diameters were measured using a caliper. 
Statistical analysis 
The purpose of the statistical analysis in this study was to determine the 
effect of differences in 0.5% chloramphenicol eye drops on the 
antibacterial effectiveness. The data of inhibition diameter for each eye 
drop preparation was processed by a statistical method using a factorial 
design, where the effectiveness of these preparations was used as an 
independent variable [26]. While the variation of preparations was 
stated as a factor A and storage time as a factor B. The results of the 
statistical test were then followed by the Newman Keuls test.  
RESULTS AND DISCUSSION 
Visual observation 
The clarity and the color of the eye drop preparations was observed to 
assess the presence of the particles visually using black and white 
background in suitable lighting. All formulas of chloramphenicol eye 
drops demonstrated as clear product and no color changes were 
occurred during the storage period at the room temperature. The results 
indicated that the chloramphenicol formulated in the eye drops did not 
undergo a photolysis reaction. This reaction must be considered as 
reported in another study that chloramphenicol in the form of an 
aqueous solution can be degraded upon exposure to sunlight [27]. 
pH evaluation 
The stability of pH values can be used as a depiction of the eye drops 
compatibility with eye physiology. pH compatibility is very 
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important to ensure the eye comfort after the eye drops used. The 
accepted pH of the eye was reported in different range based on 
several studies, in the range pH of 5.5-11.4, and a range of 4–8 [28, 
29]. The incompatibility of eye drops pH in eyes, may irritate the 
eyes and increase the tear production which may lead to the 
decrease of the chloramphenicol bioavalaibility as the active agent 
[28]. It can be concluded that the pH of the eye drop is an essential 
parameter to be considered to prevent the unexpected effects. The 
alter of pH in eye drops may be considered as the microbial 
contamination presence in the eye drops preparation. Thus, the 
further evaluation must be conducted to ensure the sterility of the 
products. In this study, the pH of all formulas was decreasing over 
the period of storage time, from 7.12 down to 7.05, presented in 
table 2 and fig. 1. Based on the pH graph, the sharpest decrease in 
pH was shown by the eye drop formula containing benzyl alcohol as 
its preservative. Whereas the pH decreasing in the F1 and F2 
formula containing benzalkonium chloride and thimerosal, 
respectively, were not significantly different. However, in this study, 
all pH formulas of chloramphenicol eye drops still fulfill the 
recommended eye pH range. 
  
Table 2: The pH changes of eye drops over storage time 
days F0 F1 F2 F3 
1 7.11±0.000 7.12±0.000 7.12±0.000 7.11±0.001 
3 7.09±0.000 7.11±0.000 7.10±0.000 7.09±0.000 
7 7.07±0.000 7.09±0.001 7.08±0.000 7.08±0.000 
14 7.06±0.001 7.07±0.000 7.08±0.000 7.08±0.000 
21 7.06±0.000 7.07±0.005 7.06±0.000 7.06±0.001 
28 7.05±0.002 7.06±0.005 7.06±0.000 7.05±0.000 
Notes: Each number of experiment replication= 3; pH changes ((mean±SD) 
 
 
Fig. 1: The pH changes of 0.5% chloramphenicol eye drops over storage time 
 
Sterility test 
The sterility of the eye drops must be maintained throughout the 
usage period [30]. Therefore, they are formulated with preservative 
to extend the use duration. Some severe eye infections have been 
reported to occur after the use of multidose eye drops due to 
pathogen contamination of multidose eye drops, which can be 
sourced from several things such as air contamination or touching 
the eye drop bottle dropper with fingers, eyelids, or eyelashes 
during dripping [31-33]. The occurrence of contaminated eye drops 
may lead to product degradation which decreasing the effectiveness 
of the product [7]. The longer the time of eye drops use, contact 
frequency of the eye drops with ocular surfaces will be mounted and 
thus the potency of getting contamination will be increased [17]. 
Therefore, formulating preservatives in eye drops is very useful for 
preventing microbial contamination during the eye drops use and 
storage. However, another study revealed that the products were 
found to be contaminated for 11%, even though they were 
formulated with benzalkonium chloride or thimerosal as 
preservatives [7, 17]. These finding indicated that the determination 
of the most effective preservative must be studied to ensure the 
sterility of the eye drops and the compatibility of the preservative 
with the active agent and others substances in the formula, by 
observing their antibacterial efficacy against the E. coli. 
The sterility of the eye drops products was consisted of fertility, 
effectiveness and sterility test. The media used in the sterility test 
have checked for its fertility to ensure that the media was capable of 
supporting the microorganism growth and the resulted of medium 
turbidity demonstrated the growth of B. subtilis and C. albicans. For 
the sterility of the used media, the incubated media showed no 
microorganism was growth. Thus, the media can be used to validate 
the sterility of the prepared eye drops containing different 
preservatives. As the result of eye drops sterility test, all formulas of 
the eye drops preparation were confirmed as sterile preparations 
during the storage period, as well as a blank formula without 
preservative content. The result illustrated that the sterilization 
process was running properly, but it cannot be described the 
preservative efficacy, due to the occurrence of eye drops blank 
sterility.  
Efficacy test  
The used of preservatives in eye drop preparation was aimed to 
prevent microbial contamination during use and storage, which may 
occur and cause product degradation or ocular infection [7]. Thus, 
eye drops as one of the sterile products that must be protected to 
maintain the product quality against the opportunistic 
contamination by selecting the most appropriate and effective 
preservative. Preservatives concentration in eye drops is limited due 
to their side effects such as irritate the eyes and damage the eyeball 
surface [34]. In this study, the preservative concentration was 
chosen in the range of its recommended concentration for ophtalmic 
product. Benzalkonium chloride is a common used preservative in 
eye drops at a concentration range from 0.004% to 0.01% [35]. The 
thimerosal preservative in ophthalmic products at typical 
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concentrations ranges of 0.001% to 0.01% (FDA). Meanwhile, benzyl 
alcohol is a preservative used at concentrations up to 2.0% v/v, but 
the frequently concentration used is 1% v/v [36-40]. But, in the 
other hand, the role of preservative to hinder eye drops 
contamination, has been controversial [41]. In fact, the eye drops’s 
shelf-life is determined by the preservatives themselves, rather than 
the main components. Expired eyedrop mean loss of preservative 
potency to protect the eye drops from microbial contamination [42]. 
Therefore, preservatives must fulfill certain requirement such as; 
compatibility with other components in the eye drops, non-toxic and 
must be efficient during the entire of use.  
The preservative employed in chloramphenicol eye-drops 
challenged with E. coli and produced strong antibacterial activity, 
performed in table 3 and illustrated in fig. 2. This showed the 
synergistic effect between chloramphenicol and the preservative 
against E. coli. The most effective antibacterial formula was shown 
by formula 2 which contained thimerosal as the preservative. In this 
study, the addition of the preservatives in all eye drops formula can 
improve the antibacterial effect of chloramphenicol, compared with 
the F0 as the blank formula containing the same concentration of 
chloramphenicol as others formula, but did not contain any 
preservatives at all. These data informed that the presence of the 
added preservatives improved the antibacterial efficacy of 
choloramphenicol in eye drop preparations. Moreover, the improve 
efficacy revealed the compatibility of the preservatives with the 
chloramphenicol as the main ingredients of the eye drops. 
  
Table 3: Inhibition effect of preservatives in 0.5% chloramphenicol eye drops 
Formula Diameter of inhibition (mm) during the storage periode (day) 
1 3 5 7 14 28 





F1 36.35±0.002 35.20±0.000 32.75±0.002 28.45±0.002 23.35±0.002 
F2 36.40±0.000 35.55±0.002 33.40±0.01 31.06±0.002 24.80±0.000 
F3 36.35±0.002 35.25±0.002 32.85±0.002 30.80±0.000 23.50±0.000 
Notes: Diameter of inhibition (mean±SD) and each number of experiment replication= 3 
 
 
Fig. 2: Antibacterial efficacy of 0.5% chloramphenicol eye drops with different preservative 
 
Based on fig. 2, it was clearly justified that F2 with thimerosal as the 
preservative, showed the highest efficacy as antibacterial against E. 
coli. The solubility and stability of chloramphenicol was important to 
be enhanced and maintained to develop an effective eye drops with 
antibacterial mechanism. It was reported that the chloramphenicol 
solubility is only 0.25% in purified water. Likewise, when the eye 
drops pH is raised to 8.6, then, its solubility achieves to 1% and may 
reduce its stability and antibacterial activity [43]. The adjustment 
pH of chloramphenicol eye drops used boric acid was one of the 
efforts to raise the required solubility of chloramphenicol. Not only 
to the chloramphenicol, the pH values also have an essential impact 
to the preservative’s action. pH can influence the rate of microbial 
growth of and the interaction between preservative with microbial 
cell wall components [44, 45]. Generally, the optimal pH for 
microbial growth is in the range of 6-8. Outside this pH range, then, 
the microbial growth rate may significantly decline. The pH of the 
product may describe the intrinsic pH of the active components, or 
the product may need pH alteration to improve product solubility, 
stability, palatability or optimal microbial effectiveness. Thimerosal 
is stable in neutral pH or weak alkaline, the benzalkonium chloride 
in the range of 4-10 and benzyl alcohol is at<pH5 [46-48]
Beside to the pH, the length of the storage time gave different effects 
on inhibition diameter in each formula. In each formula, as storage 
days increasing, the antibacterial efficacy tends to be reduced. During 
the storage period, all formulas had the decreasing in antibacterial 
potency and it might be due to the change in the pH of each formula. 
The percentage decrease in inhibition diameter occurred during the 
storage period of each formula, counted from the early storage to the 
final storage period was as follows: F0 (51.58%), F1 (35.76%), F2 
(31.86%), and F3 (35.35%). Based on those decreasing values, it can 
be concluded that the existence of preservatives have an important 
contribution in stabilizing the eye drop product, even the product 
contain antibiotics. The differences values in inhibition diameter were 
significantly influenced by the type of preservatives. It can be seen that 
. Therefore 
the antibacterial of F3 produced the smallest antibacterial activity 
against E. coli, due to the pH of F3 was lower than the optimum pH 
for benzyl alcohol action. The stability, preservatives and sterility of 
ophthalmic preparations are more stressed, rather than tonicity 
[43]. Thimerosal is a common preservative for eye drops 
preparation. However, thimerosal was found to be harmful due to its 
organic-mercury (Hg) content in thimerosal. But, the United States 
Centers for Disease Control and Prevention claimed that thimerosal 
is safe preservative and not related with the occurrence of autism 
rates in children due to the use of thimerosal-containing vaccines 
[19]. Thus, this preservative can be chosen as the effective 
preservative formulated in eye drops preparation containing 0.5% 
chloramphenicol.  
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in the absence of preservatives, the antibacterial potency of 
chloramphenicol decreased sharply over the storage time. The type of 
preservative also determined the efficacy of these chloramphenicol 
eye drops. The best formula for their stability in antibacterial potency 
was produced by F2 which used 0.01% thimerosal as its preservative, 
meanwhile the formula containing benzalkonium chloride (F1) had 
better antibacterial efficacy than that of containining benzyl alcohol 
(F3). There was a significant difference in the effect of the formula eye 
drops with respect to storage time. Based on statistical analysis, the F-
count value (6136,308) was greater than the F-table (3.0088), thus, Ho 
was rejected. It demonstrated that there was a significant difference of 
the different formulas on the inhibitory diameter. Similarly, for the 
storage time factor, the F-count value (43762,123) was greater than 
the F-table (2,6207), Ho was rejected. Therefore, there was a 
significant difference in the diameter of inhibition. In addition, the 
interaction between those treatment factors, with a Fcount-value 
(597,385) greater than F-table (2.1077) so that Ho was rejected. This 
revealed that there was a significant effect on the inhibitory diameters 
if the two levels of the factors were combined. Statistically, it can be 
concluded that different formulas give different inhibitory diameters 
(effectiveness). Based on the Newman-Keuls range test it was known 
that there were differences in the influence of the preparation formula, 
storage time and the interaction of the preparation formula with a 
significant storage time in all chloramphenicol eye drops. 
CONCLUSION 
In conclusion, all the eye drops formulas containing different 
preservatives including that of without preservative (F0) were 
physically stable during the storage period and the pH of all 
formulas have complied with the requirements for the compatibility 
with eye physiology. However, among the used preservatives, the 
chloramphenicol eye drop formula using 1% benzyl alcohol as the 
preservative shown the highest decreasing in pH and diameter of 
inhibition over the storage period. However, the eye drop formula 
without preservative demonstrated the worst stability both on 
physical and microbiological observation. Meanwhile, the formula 
that contained 0.01% thimerosal exhibited better stability than that 
of 0.01% benzalkonium chloride. Thus, it can be concluded that 
efficacy of 0.5% chloramphenicol eye drop was significantly 
influenced by the presence and the type of preservatives. From this 
present study, 0.01% thimerosal can be recommended as an 
effective preservative to be formulated in the formula of 0.5% 
chloramphenicol eye drop with respect to its product sterility and its 




All the authors have contributed equally. 
CONFLICT OF INTERESTS 
Declared none 
REFERENCES 
1. Beal C, Giordano B. Clinical evaluation of red eyes in pediatric 




Azari AA, Barney NP. Conjunctivitis: a systematic review of 
diagnosis and treatment. JAMA 2013;310:1721-9. 
4. Limberg MB. A review of bacterial keratitis and bacterial 
conjunctivitis. Am J Ophthalmol 1991;112:2S–9S. 
Epling J. Bacterial conjunctivitis. Br Med J Clin Evid 2012;2:1-21. 
5. Thadani SM, Foster CS. Treatment of ocular inflammation in 
children. Pediatr Drugs 2004;6:289–301. 
6. Høvding G. Acute bacterial conjunctivitis. Acta 
Ophthalmol 2008;86
7. Feghhi M, Mahmoudabadis AZ, Mehdinejad M. Evaluation of 
fungal and bacterial contaminations of patient-used ocular 
drops. Med Mycol 2008;46:17-21.  
:5-17. 
8. Patel PB, Diaz MC, Bennett JE, Attia MW. Clinical features of 
bacterial conjunctivitis in children. Acad Emerg Med 2007;14
9. Rietveld RP, Ter Riet G, Bindels PJ, Sloos JH, Van Weert HC. 
Predicting bacterial cause in infectious conjunctivitis: cohort 
:1-5. 
study on informativeness of combinations of signs and 
symptoms. Br Med J 2004;329:206-10. 
10. Sheikh A, Hurwitz B. Antibiotics versus placebo for acute 
bacterial conjunctivitis. Cochrane Database Syst Rev 
11. Peneva PT. Non-steroidal anti-inflammatory drugs for topical 
ophthalmic administration: contemporary trends. Int J Pharm 
Pharm Sci 2015;7:13-9.  
2006;4:CD001211. 
12. Buckley SA. Survey of patients taking topical medication at 
their first presentation to eye casualty. Br Med J 
1990;300:1497-8.  
13. Kirkness CM, Seal DV, Hay J. Topical chloramphenicol: use or 
abuse? Eye 1995;9:7-8. 
14. Hall AV, Das SS, Tabaqchali S. Is it time to stop using 
chloramphenicol on the eye? Risk is low in short courses 
[Letter]. Br Med J 1995;311:450-1. 
15. Sinclair NM, Leigh DA. A comparison of fusidic acid viscous eye 
drops and chloramphenicol eye ointment in acute 
conjunctivitis. Ther Res 1988;44:468-74.  
16. WHO. Blindness and vision impairment prevention. WHO, 
Geneva; 2020. 
17. Tsegaw A, Abula T, Assefa Y. Bacterial contamination of multi-
dose eye drops at ophthalmology department, University of 
Gondar, Northwest Ethiopia. Middle East Afr J Ophthalmol 
2017;24:81–6. 
18. Taşli H, Coşar G. Microbial contamination of eye drops. Cent 
Eur J Public Health 2001;9:162-4. 
19. Hooker B, Kern J, Geier D, Haley B, Sykes L, King P, et al. 
Methodological issues and evidence of malfeasance in research 
purporting to show thimerosal in vaccines is safe. BioMed Res 
Int 2014;1-8. https://doi.org/10.1155/2014/247218 
20. Baird RM. Guide to microbiological control in pharmaceuticals. 
CRC Press, New York; 2007. 
21. Noecker R. 
22. Klein M, Millwood EG. On the sterility of eye ointments. Br J 
Ophthal 1964;48:285-7. 
Effects of common ophthalmic preservatives on 
ocular health. R Adv Ther 2001;18:205-15. 
23. Yi Sheng C, Chiou Feng L, Chao Liang W, Pao Ying K, Fong Sen 
W, Chi Chang S, et al. Mechanisms underlying benzyl alcohol 
cytotoxicity (triamcinolone acetonide preservative) in human 
retinal pigment epithelial cells. Invest Ophth Vis Sci 
24. Abdassah M, Kusuma SAF. Comparison of thimerosal 
effectiveness in the formulation of eye drops containing 
neomycin sulfate and chloramphenicol. Int J Appl Pharm 
2019;11:130-5. 
2011;52:4214-22. 
25. Kusuma SAF, Hargono Y, Winarno H. Betalactamase enzyme 
role in minimizing false-positive result of cefotaxime injection 
end-product sterility. J Pharm Sci Res 2018;10:1036-40. 
26. Sudjana MA. Metode statistika. 8th
27. 
 ed. Penerbit Tarsito, 
Bandung; 2002. 
Shih IK. Photodegradation products of chloramphenicol in 
aqueous solution. J Pharm Sci 1971;60:
28. Jitendra, Sharma PK, Banik A, Dixit S. A new trend: ocular drug 
delivery system. Int J Pharm Sci 2011;2:1–25. 
1889-90.  
29. Lukas S. Formulasi Steril. Penerbit ANDI, Yogyakarta; 2006. 
30. British Pharmacopoeia. Efficacy of antimicrobial preservation. 
Vol. IV. Appendix XVI C A367-A369. The Stationery Office, 
London; 2007.  
31. Kallings L, Rigertz O, Silverstolpe I. Microbial contamination of 
medical preparations. Acta Pharm Sue 1966;3
32. Furrer P, Mayer JM, Gurny R. Ocular tolerance of preservatives 
and alternatives. Eur J Pharm Biopharm 2002;53:263-80. 
:199–213. 
33. Rahman MQ, Tejwani D, Wilson JA, Butcher I, Ramaesh K. Microbial 
contamination of preservative free eye drops in multiple 
application containers. Br J Ophthalmol 2006;90:139-41. 
34. Bartlett JD, Siret JD. Clinical ocular pharmacologi. 4th
35. Nelson L, Goldfrank L. Goldfrank's toxicologic emergencies. 9
 ed. 
Butterwort Heinemann; 2001. 
th
36. Croshaw B. Preservatives for cosmetics and toiletries. J Soc 
Cosmet Chem 1977;28:3–16. 
 
ed. McGraw-Hill Medical; 2011. 
37. Karabit MS, Juneskans OT, Lundgren P. Studies on the 
evaluation of preservative efficacy II: the determination of 
Kusuma et al. 
Int J App Pharm, Vol 12, Issue 4, 2020, 100-105 
105 
antimicrobial characteristics of benzyl alcohol. J Clin Hosp 
Pharm 1986;11:281–9. 
38. Shah AK, Simons KJ, Briggs CJ. Physical, chemical, and 
bioavailability studies of parenteral diazepam formulations 
containing propylene glycol and polyethylene glycol 400. Drug 
Dev Ind Pharm 1991;17:1635–54. 
39. Wallhausser KH. Benzyl alcohol. Kabara JJ. ed. Cosmetic and 
drug preservation principles and practice. Marcel Dekker, New 
York; 1984. 
40. Meyer BK, Ni A, Hu B, Shi L. Antimicrobial preservative use in 
parenteral products: past and present. J Pharm Sci 
2007;96:3155–67. 
41. Saisyo A, Oie S, Kimura K, Sonoda KH, Furukawa H. Microbial 
contamination of in-use ophthalmic preparations and its 
prevention. Bull Yamaguchi Med Sch 2016;63:17-24. 
42. Bachewar NP, Deshmukh D, Choudhari SR, Joshi RS. Evaluation 
of used eye drop containers for microbial contamination in 
outpatient department of tertiary care teaching hospital. Int J 
Basic Clin Pharmacol 2018;7:895-9. 
43. Jithan V, Mohan CK, Vimaladevi M. Development and evaluation 
of a chloramphenicol hypertonic ophthalmic solution. Indian J 
Pharm Sci 2008;70:66–70. 
44. Fassihi RA. Preservation of medicines against microbial 
contamination. In: SA Block. Ed. Disinfection Sterilization and 
Preservation. 4th
45. 
 Ed. Lea and Febiger; 1991. 
Hugo WB, Russell AD. Pharmaceutical microbiology. 6th
46. Van Horn
Ed. 
Blackwell Science; 1998. 
 DL, Edelhauser HF, Prodanovich G, Eiferman R, 
Pederson HF. Effect of the ophthalmic preservative thimerosal 
on rabbit and human corneal endothelium. Invest Ophthalmol 
Vis Sci 1977;16:273-80. 
47. Kibbe AH. Benzalkonium chloride monograph. In: Rowe RC, 
Sheskey PJ, Weller PJ. Handbook of Pharmaceutical Excipients. 
5th
48. 
 ed. Pharmaceutical Press; 2006.  
Cahill E. Benzyl alcohol monograph. In: Rowe RC, Sheskey PJ, 
Weller PJ. Handbook of Pharmaceutical Excipients. 5th
 
 ed. 
Pharmaceutical Press; 2006. 
